DSM-Firmenich AG (ETR:ZX6)

Germany flag Germany · Delayed Price · Currency is EUR
60.00
+1.12 (1.90%)
At close: Feb 26, 2026
Market Cap15.20B -43.4%
Revenue (ttm)9.03B -28.5%
Net Income-1.11B
EPS-4.27
Shares Outn/a
PE Ration/a
Forward PE21.16
Dividendn/a
Ex-Dividend Daten/a
Volume210
Average Volume742
Open59.30
Previous Close58.88
Day's Range59.08 - 60.00
52-Week Range58.88 - 114.07
Betan/a
RSI39.77
Earnings DateFeb 12, 2026

About DSM-Firmenich AG

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and s... [Read more]

Industry Chemicals and Allied Products
Founded 1902
Employees 26,873
Stock Exchange Deutsche Börse Xetra
Ticker Symbol ZX6
Full Company Profile

Financial Performance

Financial Statements

News

DSM-Firmenich AG (KDSKF) Q4 2025 Earnings Call Transcript

DSM-Firmenich AG (KDSKF) Q4 2025 Earnings Call Transcript

16 days ago - Seeking Alpha

DSM-Firmenich AG (DSFIY) Shareholder/Analyst Call Transcript

DSM-Firmenich AG (DSFIY) Shareholder/Analyst Call Transcript

20 days ago - Seeking Alpha

DSM-Firmenich AG (KDSKF) Q3 2025 Sales Call Transcript

DSM-Firmenich AG (OTC:KDSKF) Q3 2025 Sales Call October 30, 2025 4:00 AM EDT Company Participants Dave Huizing - Senior Vice President of Investor Relations Dimitri de Vreeze - Chief Executive Officer...

4 months ago - Seeking Alpha

Artisan International Value Fund Q3 2025 Portfolio Update

Major joint customer announcements about new products and significant future orders combined with strong demand for basic memory semiconductors drove renewed interest in Samsung Electronics stock. ABB...

4 months ago - Seeking Alpha

DSM-Firmenich AG (DSFIY) Q2 2025 Earnings Call Transcript

DSM-Firmenich AG (OTCQX:DSFIY) Q2 2025 Earnings Conference Call July 31, 2025 3:00 AM ET Company Participants Dave Huizing - Senior Vice President of Investor Relations Dimitri de Vreeze - Chief Execu...

7 months ago - Seeking Alpha

DSM-Firmenich AG (KDSKF) Q1 2025 Earnings Call Transcript

DSM-Firmenich AG (OTC:KDSKF) Q1 2025 Results Conference Call April 30, 2025 3:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Ralf Schmeitz - Chief Financial Officer Conference...

10 months ago - Seeking Alpha

DSM-Firmenich AG (KDSKF) Q3 2024 Earnings Call Transcript

DSM-Firmenich AG (OTC:KDSKF) Q3 2024 Earnings Conference Call October 31, 2024 4:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Dimitri de Vreeze - Chief Executive Officer Ral...

1 year ago - Seeking Alpha

DSM-Firmenich AG (KDSKF) Q2 2024 Earnings Call Transcript

DSM-Firmenich AG (OTC:KDSKF) Q2 2024 Earnings Conference Call July 30, 2024 3:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Dimitri de Vreeze - Chief Executive Officer Ralf S...

1 year ago - Seeking Alpha

DSM-Firmenich AG (KDSKF) Q1 2024 Earnings Call Transcript

DSM-Firmenich AG (OTC:KDSKF) Q1 2024 Earnings Conference Call May 2, 2024 3:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Ralf Schmeitz - Chief Financial Officer Conference C...

1 year ago - Seeking Alpha

Royal DSM: Quality At A Price

Royal DSM has proven its resilience through the near-term macro challenges. Its upcoming merger with Firmenich also appears promising and could deliver upside going forward.

3 years ago - Seeking Alpha

Koninklijke DSM N.V. (RDSMY) CEO Geraldine Matchett on Q2 2022 Results - Earnings Call Transcript

Koninklijke DSM N.V. (OTCQX:RDSMY) Q2 2022 Results Conference Call August 2, 2022 8:00 AM ET Company Participants Dave Huizing - Vice President of Investor Relations Geraldine Matchett - Chief Executi...

3 years ago - Seeking Alpha

Health and biotech firm says it has enjoyed resilient demand as health kick is here to stay

Dimitri de Vreeze, co-CEO of DSM, discusses his company's earnings and explains why demand has remained strong.

3 years ago - CNBC International TV

'A merger of equals': Firmenich CEO Ghostine on DSM deal

Firmenich CEO Gilbert Ghostine describes the company's deal with sector peer DSM as a "merger of equals."

4 years ago - CNBC International TV

5 Great Green Stocks Making a Direct Impact

It's the end of business as usual. To save the planet, consumers, companies and governments all over the world are stepping up their sustainability game, or at least pledging to do so.

4 years ago - Kiplinger

Koninklijke DSM N.V. (RDSMY) on Q4 and FY 2021 Results - Earnings Call Transcript

Koninklijke DSM N.V. (RDSMY) on Q4 and FY 2021 Results - Earnings Call Transcript

4 years ago - Seeking Alpha

DSM co-CEO: Inflationary pressures offset by 4% price increase in some business areas

Geraldine Matchett, co-CEO of DSM and member of CNBC's ESG Council, provides a deep dive into the company's fourth-quarter results and shares how DSM are tackling rising inflation.

4 years ago - CNBC International TV

Very Confident to Increase Our Outlook: DSM Co-CEO

Aug.04 -- DSM Co-CEO Dimitri de Vreeze discusses the company's earnings, emissions and sustainable foods. He speaks with Bloomberg's Anna Edwards and Mark Cudmore on "Bloomberg: European Market Open".

4 years ago - Bloomberg Markets and Finance

Koninklijke DSM NV (RDSMY) CEO Dimitri de Vreeze on Q4 2020 Results - Earnings Call Transcript

Koninklijke DSM NV (RDSMY) CEO Dimitri de Vreeze on Q4 2020 Results - Earnings Call Transcript

5 years ago - Seeking Alpha

DSM Going Into 2021 With Positive Momentum, Says Co-CEO

Feb.16 -- Geraldine Matchett, co-chief executive officer at at Dutch Lifesciences company Koninklijke DSM NV, discusses fourth-quarter earnings, the animal nutrition business and her outlook for the b...

5 years ago - Bloomberg Markets and Finance

Koninklijke DSM N.V. (RDSMY) Dimitri de Vreeze on Q3 2020 Results - Earnings Call Transcript

Koninklijke DSM N.V. (RDSMY) Dimitri de Vreeze on Q3 2020 Results - Earnings Call Transcript

5 years ago - Seeking Alpha

'Analysts failed to see the impact of foreign exchange headwinds on top line,' DSM co-CEO says

Geraldine Matchett and Dimitri de Vreeze, co-CEOs at DSM, discuss the company's third-quarter earnings and the impact of the pandemic on the business.

5 years ago - CNBC International TV

Koninklijke DSM N.V. (RDSMY) Dimitri Vreeze on Q2 2020 Results - Earnings Call Transcript

Koninklijke DSM N.V. (RDSMY) Dimitri Vreeze on Q2 2020 Results - Earnings Call Transcript

6 years ago - Seeking Alpha

DSM co-CEO's say cash generation 'is a big focus' amid the coronavirus crisis

Geraldine Matchett and Dimitri de Vreeze, co-CEO's of DSM, speak to the corporation's first half of the year along with its strategy amid the uncertainty of a second wave.

6 years ago - CNBC International TV

Koninklijke DSM NV (RDSMY) Q1 2020 Results - Earnings Call Transcript

Koninklijke DSM NV (RDSMY) Q1 2020 Results - Earnings Call Transcript

6 years ago - Seeking Alpha

Koninklijke DSM N.V. (RDSMY) CEO Feike Sijbesma on Q4 2019 Results - Earnings Call Transcript

Koninklijke DSM N.V. (RDSMY) CEO Feike Sijbesma on Q4 2019 Results - Earnings Call Transcript

6 years ago - Seeking Alpha